Abstract:BACKGROUND: Probiotics restore microbial balance and prevent gut-inflammation. Therefore, finding out novel probiotic strains is a demand. As gut-microbe, benefits of Ligilactobacillus salivarius (LS) are established. However, strain-specific detailed studies are limited. Here, we illustrate probiotic attributes of novel LS-ARS2 for its potential application as food-supplement and/or therapeutic to improve gut-health. METHODS: Whole genome sequencing (WGS) and phylogenetic analysis confirm the strain as LS. To establish probiotic properties, acid-bile tolerance, auto-aggregation, cell-surface-hydrophobicity, biofilm-formation and adhesion-assays are performed. To ensure safety attributes, antibiotic-susceptibility, haemolytic, DNase, trypan-blue and MTT assays are done. ABTS, DPPH, superoxide, hydroxyl free radical scavenging assays are used to determine anti-oxidant potential. Antibacterial assays including co-culture assay with pathogen and pathogenic biofilm-inhibition assays are performed to explore antibacterial efficacy. To characterize metabolic-profile of LS-ARS2-derived cell-free-supernatant (CFS), HRMS analysis are carried out. Consequently, WGS-analyses predict potential molecular associations related to functional outcomes. RESULTS: We find LS-ARS2 as remarkable fast-growing strain that shows acid and bile tolerance (>60% survival rate) indicating promising gut-sustainability. High auto-aggregation capacity (>80%), robust cell-surface hydrophobicity (>85%), and adhesion efficacy to Caco-2 cells illustrate significant potential of LS-ARS2 for gut colonization. Fascinatingly, LS-ARS2 is able to form biofilm within 24 h (p<0.0001), rare among LS strains, indicating the potential of the strain for efficient stay in the gut. The strain ensures safety attributes. LS-ARS2-WGS analysis recognizes probiotic-specific determinants, predicts genomic stability, identifies orthologous-clusters for diverse functions, and predicts metabolites and bacteriocins. HRMS-studies with LS-ARS2-CFS further validate the presence of diverse beneficial metabolites with antimicrobial and immunomodulatory potential. LS-ARS2 shows significant antioxidant properties in ABTS (>60%), DPPH (>10U/mL), superoxide (>70%), and hydroxyl free radical scavenging assays (>70%). Further, LS-ARS2 shows antimicrobial activities against Gram-positive Methicillin-resistant Staphylococcus aureus (MRSA) and Gram-negative multidrug-resistant clinical strains enterotoxigenic Escherichia coli, Vibrio cholerae, and Shigella flexneri. Anti-Salmonella effect of LS-ARS2 is prominent (p<0.0001). Most interestingly, LS-ARS2-CFS inhibits MRSA-biofilm (p<0.0001), again rare among LS strains. CONCLUSIONS: LS-ARS2 is a novel fast-growing, biofilm-forming probiotic with significant antioxidant, antibacterial, and anti-biofilm potentials, suggesting the promising applications of LS-ARS2 for combating pathogenic biofilms and improving gut-health. However, further in vivo studies would facilitate their potential applications.

Complete Genome Sequence of Streptococcus salivarius DB-B5, a Novel Probiotic Candidate Isolated from the Supragingival Plaque of a Healthy Female Subject

Draft Genome Sequence of Lactobacillus Reuteri Strain LR CGMCC 11154, Isolated from the Feces of Healthy Weaned Piglets

Complete Genome Sequence of Lactiplantibacillus plantarum Strain DM083 Isolated from Human Tongue Coating

Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM

Complete Genome Sequence of Streptococcus thermophilus KLDS 3.1003, A Strain with High Antimicrobial Potential against Foodborne and Vaginal Pathogens

Whole-Genome Sequence of Staphylococcus Hominis, an Opportunistic Pathogen

Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease

Complete genome sequence of Pelagibacterium halotolerans B2(T).

Genome Sequence and Biochemical Properties of Bifidobacterium longum Strain ICIS-505, Isolated from the Intestine of a Healthy Woman

Multireplicon genome architecture of Lactobacillus salivarius

Genome sequence of the New Zealand cheese isolate and candidate probiotic strain Lactiplantibacillus plantarum FNZ042

Assessment of the safety and probiotic characteristics of Lactobacillus salivarius CGMCC20700 based on whole-genome sequencing and phenotypic analysis

Complete Genome Sequence of Staphylococcus Epidermidis CCSM0287, Isolated from Healthy Facial Skin

PSII-7 Complete genome analysis of a novel mucolytic bacterium, Prevotella mucinisolvens sp. nov., isolated from bovine rumen epithelium

Complete Genome Sequence, Metabolic Profiling and Functional Studies reveal Ligilactobacillus salivarius LS-ARS2 is a Promising Biofilm-forming Probiotic with Significant Antioxidant, Antibacterial, and Antibiofilm Potential

Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2)

Probiotic functional gene explorations in the genome of Limosilactobacillus fermentum GD5MG

Whole-Genome Shotgun Sequencing of an Indian-Origin Lactobacillus helveticus Strain, MTCC 5463, with Probiotic Potential

Streptococcus salivarius 24SMBc Genome Analysis Reveals New Biosynthetic Gene Clusters Involved in Antimicrobial Effects on Streptococcus pneumoniae and Streptococcus pyogenes

Complete genome sequence of the probiotic Lacticaseibacillus paracasei LPC100 strain from the NORDBIOTIC collection isolated from a human fecal sample

Complete genome sequence of the Microbacterium sp. strain BDGP8